- Tumors709
- Pathologic Processes667
- Nervous System Diseases607
- Pathology562
- Cancer470
Any
<10 miles
<30 miles
<50 miles
<70 miles
Filter Results
Condition
- Tumors709
- Pathologic Processes667
- Nervous System Diseases607
- Pathology562
- Cancer470
Where are you looking?
How far are you willing to travel?Any
How old are you?
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
- HER2 negative
- PD-L1 positive
- ER positive
- HER2 positive
- EGFR negative
- KRAS positive
- PR positive
- EGFR positive
- ALK negative
- BRAF positive
- PD-L1 negative
- ER negative
- PR negative
- BRAF negative
- BRCA1 positive
- ROS1 negative
- BRCA2 positive
- p16 positive
- ALK positive
- CD20 positive
- HLA positive
- PIK3CA positive
- IDH positive
- MET positive
- ROS1 positive
- p16 negative
- HLA-A positive
- HR positive
- IDH negative
- MYC positive
- NRAS positive
- PALB2 positive
- TP53 positive
- BCR-ABL1 positive
- MET negative
- MSI-H positive
- MSS positive
- RET positive
- dMMR positive
- HBsAg positive
- HPV negative
- KRAS negative
- NF1 positive
- RET negative
- TP53 negative
- anti-dsDNA positive
- ABCA4 positive
- ANA positive
- BCL2 positive
- BRCA positive
- CCND1 positive
- HLA negative
- HLA-A negative
- HPV positive
- MSI-H negative
- NTRK negative
- NTRK positive
- RAS positive
- RB1 negative
- RB1 positive
- dMMR negative
- APP positive
- BCL6 positive
- BRCA1 negative
- BRCA2 negative
- CD19 positive
- CFTR positive
- COL7A1 positive
- FMR1 positive
- HRAS positive
- MDM2 positive
- MMR negative
- MMR positive
- NF2 positive
- NRAS negative
- PSEN1 positive
- PSEN2 positive
- PTEN positive
- Philadelphia Chromosome positive
- RAS negative
- RF positive
- RHO positive
- TROP2 negative
- TROP2 positive
- ctDNA positive
- pMMR positive
- 11q negative
- 11q positive
- AKT negative
- ALPL positive
- ATM positive
- Aβ1-42 positive
- C5 positive
- CD5 positive
- CLDN18.2 positive
- DLL3 positive
- DMD positive
- EBV positive
- FGFR3 positive
- FOXO1 fusion negative
- GRN positive
- HEXA positive
- HEXB positive
- HPV16 positive
- HTT positive
- IGHV positive
- JAK2 positive
- KIT positive
- MGMT negative
- MGMT positive
- MLH1 positive
- MSH2 positive
- MSH6 positive
- MSI negative
- MSS negative
- PDE6A positive
- PDE6B positive
- PIK3CA negative
- PIK3CD positive
- PIK3R1 positive
- PMS2 positive
- PTCH1 positive
- PTEN negative
- PiZZ positive
- RAF positive
- SPINK5 positive
- T790M positive
- TTR positive
- anti-PLA2R positive
- anti-Ro autoantibodies positive
- anti-Ro/SSA positive
- anti-Sm positive
- anti-Smith positive
- p53 positive
- t(11;14) positive
- 12 negative
- 12 positive
- 13q negative
- 13q positive
- 16p11.2 deletion positive
- 17p negative
- 17p positive
- 19q negative
- 19q positive
- 1p negative
- 1p positive
- 1p/19q co-deletion positive
- 1p/19q loss positive
- 1p36 deletion positive
- 46 XX karyotype positive
- 5q SMA positive
- 5q-autosomal recessive SMA positive
- AAVrh74 antibody titers negative
- ABL-class fusion positive
- ABL-class fusions positive
- ABO negative
- ABO positive
- ACD positive
- AChR positive
- AChR-Ab positive
- ADAMTS-13 negative
- ADAMTS-13 positive
- AFP positive
- AKT positive
- AKT1 positive
- APOL1 positive
- ARID1A positive
- Acetylcholine receptor antibody positive
- AchR antibodies positive
- Age-adjusted mean telomere length negative
- Anti-CCP-2 positive
- Anti-HBc IgM negative
- Anti-HBc positive
- Anti-Ro/SS-A positive
- Anti-SSA (Ro) positive
- Anti-SSB (La) positive
- Anti-Smith antibodies positive
- Antinuclear antibody positive
- Aβ1-40 positive
- Aβ1-42/Aβ1-40 ratio positive
- B7-H6 positive
- BCL-2 positive
- BCL-6 positive
- BCR-ABL1 e13a2 positive
- BCR-ABL1 e14a2 positive
- BCR-ABL1 fusion positive
- BCR-ABL1IS positive
- BRCA negative
- BTK-C481 positive
- C1-INH functional activity positive
- C1-INH positive
- C10orf2 positive
- C1INH functional levels negative
- C1INH quantitative levels negative
- C1q negative
- C4 antigen level positive
- C4 negative
- C5 p.Arg885Cys positive
- C5 p.Arg885His positive
- C9orf72 positive
- Gleason Score 10
- Gleason Score 6
- Gleason Score 7
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Stage IV
- Stage III
- Stage II
- Stage I
- 1927nm Fractional Thulium Laser Treatment
- Adjuvant Therapy (except reconstruction)
- Anti-Seizure Medications (up to 2 types)
- Any Treatment for Pancreatic Cancer
- At least one prior tumor-directed therapy
- Avoidance of Activities That Cause Joint Pain
- Biologic Anti-Neoplastic Agent
- CD4+ > 350 cells/microliter for at least twelve months
- Cancer-Directed Surgery
- Cellular Therapies for ALS
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
3791 trials
1
2
3
…50